Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1536 of 5804
-
New radiation method aims to shield brain function during cancer treatment
Disease control Recruiting nowStudy patients will receive Whole-brain radiation therapy (WBRT) - pulsed reduced dose rate (PRDR) within 14 days of registration. All patients will receive single daily fractions using 3D conformal radiotherapy. A dose of 30 Gy in 10 fractions will be delivered using the PRDR te…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New cancer drug TORL-1-23 enters first human tests
Disease control Recruiting nowThis first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-1-23 in patients with advanced cancer
Phase: PHASE1 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could laughing gas lift depression in seniors?
Symptom relief CompletedResistant Depression is a common condition in older adults and there is an urgent need for novel antidepressant in this population. Nitrous Oxide (N2O) has recently shown rapid antidepressant effect in midlife depression but no study has currently investigated the efficacy and sa…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Balloon vs stent: new hope for heart patients without permanent metal?
Disease control OngoingInternational, multicentric, prospective, investigator-driven, open-label, randomized (1:1) clinical trial to observe and evaluate the efficacy, of Magic Touch Sirolimus Coated Balloon (SCB) compared to one of the gold standard treatment for native vessel disease (everolimus-elut…
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Three extra minutes on an MRI could catch a deadly side effect of cancer treatment
Diagnosis OngoingAnti-cancer immunotherapy, one of the therapeutic revolutions of recent years. It is based on the use of antibodies that block immune system checkpoints that have been hijacked by cancer cells to benefit themselves. Blocking these checkpoints, such as PD-1, unleashes the action o…
Phase: NA • Sponsor: Centre Chirurgical Marie Lannelongue • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
Can schools and doctors together boost HPV shots in teens?
⭐️ VACCINE ⭐️ CompletedThis study aims at evaluating the effectiveness, efficiency and implementation of a multicomponent intervention (components being applied in combination or alone) on the acceptability of HPV vaccine among French adolescents (11-14 years old) through a cluster randomized controlle…
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:03 UTC
-
New drug combo targets tough adrenal cancer
Disease control Ongoing* Clinical Indication : Advanced adrenal cortical carcinoma after platinum-based chemotherapy * Trial Type : Single arm, prospective trial * Route of administration : Intravenous (pembrolizumab) and peroral (lenvatinib) * Treatment Groups : Single arm * Number of trial participan…
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug may tame Life-Threatening side effects of cancer immunotherapy
Disease control CompletedThis study will evaluate the use of siltuximab to decrease the severity of cytokine release syndrome (CRS) and immune effector cell-associated neurological syndrome (ICANS) in patients who will receive chimeric antigen receptor (CAR) T-cell therapy for the treatment of hematologi…
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
HIV-Positive kidneys for HIV-Positive patients: a lifesaving match?
Disease control Recruiting nowThe U.S. Department of Health and Human Services (HHS), through the National Institutes of Health (NIH), published Final Human Immunodeficiency Virus (HIV) Organ Policy Equity (HOPE) Act Safeguards and Research Criteria for Transplantation of Organs Infected With HIV. All such tr…
Sponsor: Tulane University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New program aims to keep seniors strong and independent longer
Prevention CompletedFrailty is a geriatric syndrome characterized by a decrease in the function of various organs and systems that leads to a greater risk of suffering from diseases or disabilities. Frailty is usually accompanied by weight loss, loss of strength, slowing of walking speed, fatigue an…
Phase: NA • Sponsor: Consorci Sanitari del Maresme • Aim: Prevention
Last updated Jun 27, 2026 12:01 UTC
-
Smaller incisions, big hopes: new surgery for stomach cancer under trial
Disease control OngoingThe aim of this study is to verify the safety and efficacy of single or reduced ports laparoscopic gastrectomy for advanced gastric cancer.
Phase: NA • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New blood test could save lives in liver failure bleeding emergencies
Disease control CompletedIn this project, we plan to evaluate whether a new, rotational thromboelastometry-guided algorithm (ROTEM) to guide hemostatic resuscitation decreases the use of allogeneic blood products, the total amount of bleeding, transfusion related side effects, thromboembolic complication…
Phase: NA • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Double radiation attack shows promise for returning prostate cancer
Disease control CompletedParticipants will either receive treatment with standard SBRT and the study drug Radium (Ra-223) dichloride, or standard SBRT alone.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New combo therapy hopes to tame advanced cancers
Disease control OngoingThis is an investigator-initiated industry-supported phase 1 clinical trial conducted in the phase 1 clinic at The University of Texas MD Anderson Cancer Center who will hold the Investigational New Drug (IND). Lvygen Biopharma will provide as investigational supply LVGN3616, LVG…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New study aims to cut opioid use in transgender surgery recovery
Symptom relief Recruiting nowThis study will compare the current standard-of-care pain treatment regimen options that are available to patients who undergo gender-affirming surgery. The purpose of this research is to determine if any of these options are more (versus less) effective than the others to manage…
Phase: PHASE3 • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 26, 2026 17:38 UTC
-
Bringing the gym to the farm: could a tailored home workout beat cancer fatigue?
Symptom relief OngoingThe objective of this investigation is to establish the feasibility and initial effectiveness of a novel exercise program for rural cancer survivors in Colorado suffering from cancer related fatigue. Participation in an exercise program has regularly been shown to reduce fatigue …
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New combo therapy shows promise in shrinking esophageal tumors before surgery
Disease control OngoingThis is an exploratory phase II clinical study designed to evaluate the safety and efficacy of Camrelizumab in combination with standard radiotherapy as preoperative neoadjuvant therapy for patients with resectable esophageal squamous cell carcinoma. In the study, all eligible su…
Phase: PHASE1, PHASE2 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New study tests if trikafta helps CF patients breathe easier during exercise
Disease control Recruiting nowShortness of breath (dyspnea) during exercise is a major source of distress and is a commonly reported symptom in patients with cystic fibrosis (CF). A recent drug treatment option known as Trikafta, which contains elexacaftor, tezacaftor, and ivacaftor, may be used in patients w…
Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Blood markers could transform liver cancer surveillance
Knowledge-focused OngoingHepatocellular carcinoma (HCC) is the 4th most common cause of cancer death globally but only 20% are diagnosed in its early stages where curative treatment can be carried out. Current standard-of-care surveillance of patients at high risk of developing HCC with 6-monthly serum a…
Sponsor: National Cancer Centre, Singapore • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Heart rhythm crisis in sepsis: which strategy saves more lives?
Disease control Recruiting nowNew-onset supraventricular arrhythmia (NOSVA) is reported in 40 % of patients with septic shock and is associated with hemodynamic alterations and mortality. The lack of consensus regarding best practices for the management of NOSVA in this setting has led to major variations in …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC